Loading...

Biocorp Production

ALCOR.PA•EURONEXT
Healthcare
Medical - Devices
€35.10
€0.10(0.29%)

Biocorp Production (ALCOR.PA) Stock Overview

Explore Biocorp Production’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.8/100

Key Financials

Market Cap154.5M
P/E Ratio-237.09
EPS (TTM)$-0.15
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$30.25

ALCOR.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biocorp Production (ALCOR.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $30.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -237.09 and a market capitalization of 154.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for ALCOR.PAStats details for ALCOR.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ALCOR.PAAnalyst Recommendations details for ALCOR.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Biocorp Production designs, develops, and manufactures medical devices and drug delivery systems in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Onejet, a motor driven disposable auto-injector designed to deliver viscosity products; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France.

CEO

Eric Dessertenne

Employees

75

Headquarters

Parc Technologique, Issoire

Founded

2015

Frequently Asked Questions

;